Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages 3827-3837

  Smith, Terry J ^a,b   Padovani Claudio, Dolly A ^a   Lu, Ying ^a   Raychaudhuri, Nupur ^a   Fernando, Roshini ^a   Atkins, Stephen ^a   Gillespie, Erin F ^a   Gianoukakis, Andrew G ^c   Miller, Barbra S ^a   Gauger, Paul G ^a   Doherty, Gerard M ^a   Douglas, Raymond S ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DEXAMETHASONE; INTERLEUKIN 6; INTERLEUKIN 8; LUGOL; PROPYLTHIOURACIL; PROTEIN KINASE B INHIBITOR; ROSIGLITAZONE; SMALL INTERFERING RNA; THIAMAZOLE; THYROTROPIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; ADULT; AGED; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ORBIT; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; THYROID GLAND; THYROIDECTOMY;

ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FIBROBLASTS; GRAVES DISEASE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; ORBIT; RECEPTORS, THYROTROPIN; THYROID GLAND; THYROIDECTOMY;

EID: 83155177164     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1249     Document Type: Article

References (48)

1. Brent GA 2010 Graves' disease. N Engl J Med 358:24
2. Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, Rapoport B 2002 Thyroid-stimulating autoantibodies in Graves' disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209-217 (Pubitemid 34787358)
3. Davies TF, Ando T, Lin RY, Tomer Y, Latif R 2005 Thyrotropin receptor-associated diseases: from adenomata to Graves' disease. J Clin Invest 115:1972-1983 (Pubitemid 41134132)
4. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738
5. Kazim M, Goldberg RA, Smith TJ 2002 Insights into the pathogenesis of thyroid-associated orbitopathy. Arch Ophthalmol 120:380-386
6. Yoshihara A, Yoshimura Noh J, Nakachi A, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Inoue Y, Ito K, Ito K 2011 Severe thyroid-associated orbitopathy in Hashimoto's thyroiditis. Report of 2 cases. Endocr J 58:343-348
7. Feliciello A, Porcellini A, Ciullo I, Bonavolontà G, Avvedimento EV, Fenzi G 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342:337-338 (Pubitemid 23227563)
8. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF 2003 TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 58:280-287 (Pubitemid 36308115)
9. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS 1993 Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 3:297-300 (Pubitemid 24015323)
10. Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M 2003 Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol 30:369-380 (Pubitemid 36722625)
11. Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M 2005 Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur J Endocrinol 152:777-784 (Pubitemid 40744547)
12. Douglas RS, Afifiyan NF, Hwang CJ, Chong K, Haider U, Richards P, Gianoukakis AG, Smith TJ 2010 Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 95:430-438
13. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A 1994 Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71-81
14. Pilling D, Fan T, Huang D, Kaul B, Gomer RH 2009 Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4:e7475
15. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM 2004 Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438-446 (Pubitemid 39071616)
16. Wada T, Sakai N, Matsushima K, Kaneko S 2007 Fibrocytes: a new insight into kidney fibrosis. Kidney Int 72:269-273 (Pubitemid 47172378)
17. Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ 2008 Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol 181:4397-4405
18. Smith TJ, Sempowski GD, Berenson CS, Cao HJ, Wang HS, Phipps RP 1997 Human thyroid fibroblasts exhibit a distinctive phenotype in culture: characteristic ganglioside profile and functional CD40 expression. Endocrinology 138:5576-5588 (Pubitemid 27509724)
19. Gianoukakis AG, Douglas RS, King CS, Cruikshank WW, Smith TJ 2006 Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology 147:1941-1949
20. Gianoukakis AG, Jennings TA, King CS, Sheehan CE, Hoa N, Heldin P, Smith TJ 2007 Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts. Endocrinology 148:54-62 (Pubitemid 46021437)
21. Hikim AP, Lue Y, Yamamoto CM, Vera Y, Rodriguez S, Yen PH, Soeng K, Wang C, Swerdloff RS 2003 Key apoptotic pathways for heat-induced programmed germ cell death in the testis. Endocrinology 144:3167-3175 (Pubitemid 36819919)
22. Smith TJ 1987 n-Butyrate inhibition of hyaluronate synthesis in cultured human fibroblasts. J Clin Invest 79:1493-1497 (Pubitemid 17099655)
23. Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP 1995 Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab 80:2620-2625
24. Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A 2002 Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 87:385-392
25. Chen B, Tsui S, Smith TJ 2005 IL-1β induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. J Immunol 175:1310-1319 (Pubitemid 41095021)
26. Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM 2007 Differentiation of human circulating fibrocytes as mediated by transforming growth factor-β and peroxisome proliferator-activated receptor γ. J Biol Chem 282:22910-22920 (Pubitemid 47267358)
27. Sorisky A, Pardasani D, Gagnon A, Smith TJ 1996 Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab 81:3428-3431 (Pubitemid 26296229)
28. Suh JM, Song JH, Kim DW, Kim H, Chung HK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH, Cho BY, Ro HK, Shong M 2003 Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J Biol Chem 278:21960-21971 (Pubitemid 36792604)
29. Smith TJ 2005 Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol 141:388-397 (Pubitemid 41075861)
30. Davies TF, Teng CS, McLachlan SM, Smith BR, Hall R 1978 Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes. Mol Cell Endocrinol 9:303-310
31. Endo T, Ohno M, Kotani S, Gunji K, Onaya T 1993 Thyrotropin receptor in non-thyroid tissues. Biochem Biophys Res Commun 190:774-779 (Pubitemid 23207832)
32. Busuttil BE, Frauman AG 2001 Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues. J Clin Endocrinol Metab 86:2315-2319 (Pubitemid 32472957)
33. Agretti P, Chiovato L, De Marco G, Marcocci C, Mazzi B, Sellari-Franceschini S, Vitti P, Pinchera A, Tonacchera M 2002 Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues. Eur J Endocrinol 147:733-739 (Pubitemid 36032961)
34. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A 2000 Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol 279:C335-C340
35. Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M, Persechino S, Zambruno G, Ulisse S, Odorisio T, D'Armiento M 2010 TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol 130:93-101
36. Borrello MG, Alberti L, Fischer A, Degl'innocenti D, Ferrario C, Gariboldi M, Marchesi F, Allavena P, Greco A, Collini P, Pilotti S, Cassinelli G, Bressan P, Fugazzola L, Mantovani A, Pierotti MA 2005 Induction of a proinflammatory program in normal human thyrocytes by the RET/PTCI oncogene. Proc Natl Acad Sci USA 102:14825-14830 (Pubitemid 41457140)
37. Armengol MP, Cardoso-Schmidt CB, Fernández M, Ferrer X, Pujol-Borrell R, Juan M 2003 Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J Immunol 170:6320-6328 (Pubitemid 36682618)
38. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E, Serio M 2004 High levels of circulating CSC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89:5496-5499 (Pubitemid 39518431)
39. Hidaka Y, Okumura M, Fukata S, Shimaoka Y, Takeoka K, Tada H, Kuma K, Amino N 1999 Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease. Thyroid 9:149-153 (Pubitemid 29115535)
40. Ajjan RA, Watson PF, Weetman AP 1997 Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 82:666-669 (Pubitemid 27068648)
41. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP 2003 Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:207-213 (Pubitemid 36918657)
42. Molnár I, Balázs C 1997 High circulating IL-6 levels in Graves' ophthalmopathy. Autoimmunity 25:91-96 (Pubitemid 27196644)
43. Chesney J, Bacher M, Bender A, Bucala R 1997 The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naïve T cells in situ. Proc Natl Acad Sci USA 94:6307-6312 (Pubitemid 27270680)
44. Valyasevi RW, Erickson DZ, Harteneck DA, Dutton CM, Heufelder AE, Jyonouchi SC, Bahn RS 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 84:2557-2562
45. Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M 2000 Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci 41:3249-3255
46. van Zeijl CJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, Wiersinga WM, Miltenburg AMM, Boelen A 2011 Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways. Thyroid 21:169-176
47. Keeley EC, Mehrad B, Strieter RM 2011 The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair 4:2
48. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN 2001 Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15:2215-2224 (Pubitemid 32927939)